Key takeaways:
Losartan (Cozaar) belongs to a group of medications called angiotensin II receptor blockers (ARBs). It treats health conditions like high blood pressure, heart failure, and kidney problems from diabetes.
Unlike some other medications that treat high blood pressure, losartan lowers blood pressure without affecting your heart rate.
Losartan begins working with your first dose. But it can take several weeks before the medication’s full effects take hold.
Losartan (Cozaar) is one of the most commonly prescribed medications in the U.S. It’s approved to treat a few health conditions, including high blood pressure and kidney problems from diabetes. Losartan is also prescribed “off-label” for other conditions, like heart failure.
In this article, we explore losartan’s mechanism of action, or how it works. We’ll also cover how it’s used to treat a variety of conditions.
Losartan belongs to a group of medications called angiotensin II receptor blockers (ARBs). ARBs treat several health conditions, including hypertension (high blood pressure). Other examples of ARBs include olmesartan (Benicar), telmisartan (Micardis), and valsartan (Diovan).
Losartan comes as generic tables and brand-name tablets (Cozaar). Typically, it’s taken once a day, with or without food.
Losartan works by blocking angiotensin II from acting on angiotensin II receptors. But what does that mean in practical terms? Below, we’ll outline how losartan’s mechanism of action allows it to treat a variety of conditions.
Angiotensin II is a hormone that increases blood pressure. It does this in three major ways:
Constricting (tightening) the walls of your blood vessels (particularly, your arteries)
Signaling your adrenal glands to release aldosterone, a hormone that increases blood pressure by causing the body to hold onto sodium and water
Acting directly on your kidneys to decrease the amount of sodium and water that leaves the body through your urine
Combined, these effects increase blood pressure, which is where losartan comes in. Losartan blocks angiotensin II type 1 receptors, the binding sites angiotensin II attaches to. By blocking these receptors, losartan prevents the three actions discussed above and decreases blood pressure.
The most common type of stroke is an ischemic stroke. This type of stroke is caused by a blockage in the brain or a blockage elsewhere in that body that travels to the brain. Most often, this is due to plaque buildup in a blood vessel that then breaks and forms a blood clot. These clots can block blood flow to the brain, resulting in a stroke.
Losartan treats one of the major risk factors for stroke: high blood pressure. It also helps prevent strokes by improving the health of blood vessels, making it less likely that plaque buildup worsens and forms clots that get stuck.
By lowering blood pressure, losartan also helps protect your heart. High blood pressure can damage your heart in several ways. For example, high blood pressure decreases blood flow to the heart by damaging essential arteries. Over time, this can lead to chest pain, heart attack, or heart failure.
By blocking angiotensin II, losartan can prevent or minimize “cardiac remodeling.” This is a process in which damage to the heart causes undesirable changes to its structure and function. Cardiac remodeling, which contributes to the development of heart failure, was originally thought to occur only after a heart attack. But now we know that many health conditions can cause these changes, including hypertension and inflammation in the heart (myocarditis).
Losartan also helps protect the kidneys in many ways, including by:
Decreasing blood pressure, which is known to protect the kidneys and prevent kidney disease from worsening
Decreasing the amount of protein in the urine, which is associated with kidney disease
Decreasing certain substances that cause inflammation in the kidneys
Decreasing blood levels of uric acid, a substance that has been linked to heart problems, diabetes, and kidney problems
Losartan has several FDA-approved and off-label uses. Off-label use refers to prescribing a medication for a different condition than what it was FDA approved to treat.
To start with, losartan is FDA approved to:
Treat high blood pressure (hypertension) in adults and children who are at least 6 years old
Treat kidney problems from diabetes (diabetic nephropathy) in some adults with Type 2 diabetes and hypertension
Lower the risk of stroke in some adults with hypertension and left ventricular hypertrophy (a condition in which the left side of the heart is enlarged)
Off-label uses of losartan include:
Treating heart failure in people who can’t tolerate other, first-choice medications like sacubitril / valsartan (Entresto) or lisinopril (Zestril)
Treating kidney disease not caused by diabetes
Preventing further damage after a heart attack in people who can’t take angiotensin-converting enzyme (ACE) inhibitors
Treating Marfan syndrome (an inherited condition that can cause high blood pressure)
Losartan may start working with your first dose, but you won’t feel its full effects immediately.
If you’re taking losartan for hypertension, you’ll likely notice a drop in blood pressure within 1 week after starting treatment. But it may take up to 3 to 6 weeks for the medication’s full blood-pressure-lowering effects to take hold.
The effects of losartan may be less obvious if you’re taking it for a condition other than hypertension. But this doesn’t mean you should stop taking the medication. If you have any concerns about whether losartan is working for you, talk to your healthcare provider.
There are many medications that treat hypertension. These include:
Below, we’ll focus on how losartan is different from ACE inhibitors and diuretics, since these are two common types of blood pressure medication.
ACE inhibitors are the most similar group of medications to ARBs, including losartan. Examples of ACE inhibitors are lisinopril and benazepril (Lotensin).
ACE inhibitors and ARBs treat many of the same conditions and work in similar ways. They both block the actions of angiotensin II. But ACE inhibitors block the enzyme (protein) that is required to produce angiotensin II, whereas ARBs block angiotensin II receptors.
In general, ACE inhibitors and ARBs work similarly well. But ACE inhibitors are considered to have more side effects, including cough. While losartan can also cause cough, it’s not as common.
Diuretics lower blood pressure by increasing the amount of fluid and sodium that leaves your body. Different diuretics work in slightly different ways, and some have a stronger effect on blood pressure than others. Because of their effects on blood pressure, thiazide diuretics, like hydrochlorothiazide (Microzide) and chlorthalidone (Thalitone), are first-choice treatment options for treating hypertension.
Diuretics work differently than losartan and have their own side effects. One of the most notable risks with diuretics is electrolyte changes. Diuretics can cause:
Hypokalemia (low potassium levels) or hyperkalemia (high potassium levels), which is less common but seen with some diuretics like spironolactone (Aldactone)
Hyponatremia (low sodium levels)
Hypomagnesemia (low magnesium levels)
Hypercalcemia (high calcium levels)
While losartan can cause hyperkalemia (high potassium), it’s not known to cause other electrolyte changes. Unlike thiazides, losartan also doesn’t cause sensitivity to the sun, and it’s less likely to cause sexual problems. In fact, losartan may even improve sexual problems in some people with high blood pressure. Both losartan and thiazides can cause dizziness and tiredness, however.
Losartan (Cozaar) is an angiotensin II receptor blocker (ARB) that treats many health conditions, including high blood pressure (hypertension) and kidney problems from diabetes (diabetic nephropathy). It also helps prevent strokes in some people. In addition to these FDA-approved uses, it can also help treat heart failure, Marfan syndrome, and kidney disease in some people.
Losartan’s mechanism of action is complex. It works by blocking the actions of angiotensin II, a hormone that increases blood pressure. It does this by blocking it from attaching to angiotensin II receptors, which also helps prevent damage to the kidneys and heart.
American Heart Association. (2022). How high blood pressure can lead to a heart attack.
American Heart Association. (2022). Myocarditis.
American Stroke Association. (2023). Atherosclerosis and stroke.
Bornstein, A. B., et al. (2023). Left ventricular hypertrophy. StatPearls.
Burnier, M. (2001). Angiotensin II type 1 receptor blockers. Circulation.
Centers for Disease Control and Prevention. (2021). High blood pressure symptoms and causes.
Díez, J. (2006). Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension. Clinical Therapeutics.
Gjesdal, O., et al. (2011). Cardiac remodeling at the population level—Risk factors, screening, and outcomes. Nature Reviews Cardiology.
Heidenrich, P. A., et al. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation.
Jiang, F., et al. (2018). Cellular and molecular mechanisms of polyphenol-induced beneficial effects on cardiac remodeling. Polyphenols: Prevention and Treatment of Human Disease.
Katsiki, N., et al. (2018). Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)—Lessons learned for losartan: An ‘old dog playing good tricks’. The Journal of Clinical Hypertension.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2013). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements.
Park, H. C., et al. (2003). Effect of losartan and amlodipine on proteinuria and transforming growth factor‐β1 in patients with IgA nephropathy. Nephrology Dialysis Transplantation.
Patel, P., et al. (2023). Angiotensin II. StatPearls.
RemedyRepack Inc. (2023). Losartan potassium - losartan tablet [package insert].
Ripley, E., et al. (2010). Fifteen years of losartan: What have we learned about losartan that can benefit chronic kidney disease patients? International Journal of Nephrology and Renovascular Disease.
Van Andel, M. M., et al. (2020). Long-term clinical outcomes of losartan in patients with Marfan syndrome: Follow-up of the multicentre randomized controlled COMPARE trial. European Heart Journal.
Xu, F., et al. (2011). Cardiovascular effects of losartan and its relevant clinical application. Current Medicinal Chemistry.
You and Your Hormones. (2019). Angiotensin. Society for Endocrinology.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.